AngioDynamics

AngioDynamics AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by

AngioDynamics’ history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach. Queensbury was chosen due to its location in the heart of "Catheter Valley," an area in New York's Adirondack Region named for its long history of catheter and other medical device manufacturin

g. Today, the Company has made its presence apparent far beyond Upstate New York with 1,300 employees worldwide at facilities in the United States, Europe, and Asia. AngioDynamics is currently selling in more than 50 markets through direct sales and distributors. Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Through acquisitions of companies such as RITA Medical Systems in January 2007, Oncobionic in May 2008, and the assets of Diomed in June 2008 and FlowMedica in January 2009, AngioDynamics now boasts a diverse product line that includes market-leading thermal and non-thermal ablation systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, venous products and targeted renal therapy products. Continuing its expansion, in May 2012, AngioDynamics acquired Navilyst Medical, bringing market-leading fluid management systems into its portfolio. The acquisition significantly expanded the Company's scale, doubling its share of the vascular access market while building critical mass in the peripheral vascular market. A comprehensive look at the Company's history can be found in the form of an interactive timeline of events at www.angiodynamics.com.

05/20/2026

Thoughtful design and dependable access for long-term therapy - the BioFlo implantable port with Endexo technology.

Visit us: BioFlo Ports | AngioDynamics

Risk info: Medical Technologies and Devices Risk Information | AngioDynamics



1. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file.

05/07/2026

SmartPort+ implantable ports with Endexo technology have the potential to reduce thrombus, fibrin sheath, and clot formations, potentially leading to lower procedural costs and improved patient outcomes.

Make the switch to SmartPort+ implantable ports and see the difference.

For full risk information, please visit: www.angiodynamics.com/about-us/risk-information.

+

We pause to recognize the unwavering dedication, compassion, and expertise nurses bring to healthcare every day. Your co...
05/06/2026

We pause to recognize the unwavering dedication, compassion, and expertise nurses bring to healthcare every day. Your commitment to patients and the resilience you show in every challenge inspire all of us.

We’re honored to support your work with innovative medical devices that help empower the care you deliver.

Thank you. This week and always, we celebrate you.

🚀 AngioDynamics is Hiring – Territory Manager, Oncology (NanoKnife) | Denver, COAngioDynamics is hiring in our Oncology ...
04/23/2026

🚀 AngioDynamics is Hiring – Territory Manager, Oncology (NanoKnife) | Denver, CO

AngioDynamics is hiring in our Oncology division and we are looking for a driven Territory Manager to support the Denver, CO markets. This role focuses on expanding adoption of our innovative NanoKnife System, the only function-preserving therapy that uses electricity to destroy prostate tumors.

This is an exciting opportunity to partner with leading physicians and health systems while bringing advanced tumor treatment technology to patients who need it most.

In this role, you will:
• Drive territory growth and expand adoption of the NanoKnife platform
• Build strong partnerships with surgeons, interventional specialists, and hospital teams
• Provide procedural support and clinical expertise during cases
• Deliver product education and training to clinical staff
• Develop and execute strategic territory plans to grow the oncology business

We’re seeking a motivated sales professional with experience in oncology, surgical oncology, urology, or interventional medical devices who thrives in a clinical, fast-paced environment.

📩 Apply today or message me for more details! https://jobs.dayforcehcm.com/en-US/angio/AngioCareers/jobs/4100

It may look like a smile – and honestly, it fits. The kink-resistant shaft is designed to recover rapidly, even when it’...
04/22/2026

It may look like a smile – and honestly, it fits.

The kink-resistant shaft is designed to recover rapidly, even when it’s bent, twisted, or knotted, helping maintain freer flow and clog-free drainage.

A catheter that keeps its shape gives everyone a reason to smile.

Visit us: Drainage Catheters | AngioDynamics

Risk info: Medical Technologies and Devices Risk Information | AngioDynamics

Click the link to find a sales rep near you ▶️ https://lnkd.in/e3BX47J5

04/21/2026

Supporting long‑term therapy with thoughtful design and dependable access — the BioFlo implantable port with Endexo technology.

Visit us: BioFlo Ports | AngioDynamics

Risk info: Medical Technologies and Devices Risk Information | AngioDynamics



1. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file

Address

14 Plaza Drive
Latham, NY
12110

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+15187951400

Alerts

Be the first to know and let us send you an email when AngioDynamics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AngioDynamics:

Share